Loading…

Metabolic Tumor Volume Predicts Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Loncastuximab Tesirine in the Lotis-2 Trial

Saved in:

Bibliographic Details
Published in:	Blood 2022-11, Vol.140 (Supplement 1), p.6650-6652
Main Authors:	Alderuccio, Juan Pablo, Kuker, Russ A, Reis, Isildinha M, Nachiappan, Muthiah, Kahl, Brad S., Hamadani, Mehdi, Ai, Weiyun Z., Radford, John, Solh, Melhem, Ardeshna, Kirit M., Hess, Brian T., Lunning, Matthew A., Zinzani, Pier Luigi, Stathis, Anastasios, Carlo-Stella, Carmelo, Yu, Eric, Caimi, Paolo F, Kwon, Deukwoo, Lossos, Izidore S., Yang, Fei, Moskowitz, Craig H.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!